nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—endothelium—malignant glioma	0.0474	0.122	CbGeAlD
Etomidate—SLC2A1—blood vessel—malignant glioma	0.0437	0.113	CbGeAlD
Etomidate—SLC2A1—embryo—malignant glioma	0.0261	0.0673	CbGeAlD
Etomidate—SLC2A1—brainstem—malignant glioma	0.0239	0.0617	CbGeAlD
Etomidate—SLC2A1—retina—malignant glioma	0.023	0.0595	CbGeAlD
Etomidate—SLC2A1—telencephalon—malignant glioma	0.0212	0.0548	CbGeAlD
Etomidate—SLC2A1—midbrain—malignant glioma	0.0152	0.0393	CbGeAlD
Etomidate—SLC2A1—spinal cord—malignant glioma	0.0148	0.0384	CbGeAlD
Etomidate—SLC2A1—central nervous system—malignant glioma	0.012	0.0311	CbGeAlD
Etomidate—SLC2A1—cerebellum—malignant glioma	0.0118	0.0304	CbGeAlD
Etomidate—SLC2A1—brain—malignant glioma	0.00956	0.0247	CbGeAlD
Etomidate—GABRB2—brainstem—malignant glioma	0.00931	0.0241	CbGeAlD
Etomidate—GABRB2—telencephalon—malignant glioma	0.00826	0.0214	CbGeAlD
Etomidate—GABRG2—telencephalon—malignant glioma	0.00826	0.0214	CbGeAlD
Etomidate—Pseudoephedrine—IL2—malignant glioma	0.00823	0.228	CrCbGaD
Etomidate—GABRA1—brainstem—malignant glioma	0.00822	0.0213	CbGeAlD
Etomidate—GABRA1—telencephalon—malignant glioma	0.0073	0.0189	CbGeAlD
Etomidate—Diethylpropion—SLC6A3—malignant glioma	0.00665	0.184	CrCbGaD
Etomidate—GABRB2—medulla oblongata—malignant glioma	0.00649	0.0168	CbGeAlD
Etomidate—GABRG2—medulla oblongata—malignant glioma	0.00649	0.0168	CbGeAlD
Etomidate—GABRB2—midbrain—malignant glioma	0.00593	0.0153	CbGeAlD
Etomidate—GABRG2—midbrain—malignant glioma	0.00593	0.0153	CbGeAlD
Etomidate—GABRG2—spinal cord—malignant glioma	0.00579	0.015	CbGeAlD
Etomidate—GABRB2—spinal cord—malignant glioma	0.00579	0.015	CbGeAlD
Etomidate—GABRA1—medulla oblongata—malignant glioma	0.00573	0.0148	CbGeAlD
Etomidate—GABRA1—midbrain—malignant glioma	0.00524	0.0135	CbGeAlD
Etomidate—GABRA1—spinal cord—malignant glioma	0.00511	0.0132	CbGeAlD
Etomidate—GABRB2—central nervous system—malignant glioma	0.0047	0.0121	CbGeAlD
Etomidate—GABRG2—central nervous system—malignant glioma	0.0047	0.0121	CbGeAlD
Etomidate—GABRB2—cerebellum—malignant glioma	0.00459	0.0119	CbGeAlD
Etomidate—GABRG2—cerebellum—malignant glioma	0.00459	0.0119	CbGeAlD
Etomidate—GABRA1—central nervous system—malignant glioma	0.00415	0.0107	CbGeAlD
Etomidate—GABRA1—cerebellum—malignant glioma	0.00405	0.0105	CbGeAlD
Etomidate—CYP19A1—central nervous system—malignant glioma	0.00381	0.00984	CbGeAlD
Etomidate—Ephedrine—BCHE—malignant glioma	0.00378	0.105	CrCbGaD
Etomidate—GABRG2—brain—malignant glioma	0.00373	0.00964	CbGeAlD
Etomidate—GABRB2—brain—malignant glioma	0.00373	0.00964	CbGeAlD
Etomidate—Pethidine—CYP2B6—malignant glioma	0.00363	0.101	CrCbGaD
Etomidate—GABRA1—brain—malignant glioma	0.00329	0.00851	CbGeAlD
Etomidate—Fenoprofen—PTGS1—malignant glioma	0.00317	0.0877	CrCbGaD
Etomidate—Pethidine—SLC6A3—malignant glioma	0.00309	0.0857	CrCbGaD
Etomidate—CYP19A1—brain—malignant glioma	0.00302	0.00781	CbGeAlD
Etomidate—Pseudoephedrine—SLC6A3—malignant glioma	0.00299	0.0827	CrCbGaD
Etomidate—Pseudoephedrine—TNF—malignant glioma	0.00278	0.0769	CrCbGaD
Etomidate—Fenoprofen—PTGS2—malignant glioma	0.00181	0.0501	CrCbGaD
Etomidate—GABRG2—Neuronal System—BRAF—malignant glioma	0.00031	0.000538	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—KNG1—malignant glioma	0.00031	0.000537	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000307	0.000532	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000307	0.000532	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BCAN—malignant glioma	0.000306	0.00053	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000305	0.000528	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000304	0.000527	CbGpPWpGaD
Etomidate—SLC2A1—Disease—FGF2—malignant glioma	0.000303	0.000525	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CG—malignant glioma	0.000301	0.000522	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000299	0.000517	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000296	0.000514	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000295	0.000512	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000294	0.00051	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000292	0.000506	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PPARG—malignant glioma	0.000291	0.000504	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BCHE—malignant glioma	0.00029	0.000503	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—malignant glioma	0.000287	0.000497	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC5A5—malignant glioma	0.000287	0.000497	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MDM2—malignant glioma	0.000284	0.000492	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MDM2—malignant glioma	0.000283	0.000491	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—RAF1—malignant glioma	0.000283	0.000491	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR4—malignant glioma	0.000283	0.00049	CbGpPWpGaD
Etomidate—SLC2A1—Disease—RAF1—malignant glioma	0.000282	0.000489	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000282	0.000489	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB2—malignant glioma	0.000279	0.000484	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KNG1—malignant glioma	0.000277	0.00048	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CB—malignant glioma	0.000276	0.000478	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000275	0.000476	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000275	0.000476	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—malignant glioma	0.000273	0.000473	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNA2—malignant glioma	0.000271	0.00047	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—BRAF—malignant glioma	0.000271	0.00047	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000271	0.00047	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS1—malignant glioma	0.000269	0.000466	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000269	0.000466	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000269	0.000465	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000268	0.000465	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000268	0.000464	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CD—malignant glioma	0.000265	0.000459	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000263	0.000455	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000261	0.000452	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MDM2—malignant glioma	0.00026	0.00045	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—RAF1—malignant glioma	0.000259	0.000449	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SOD1—malignant glioma	0.000257	0.000446	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR4—malignant glioma	0.000257	0.000445	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000255	0.000441	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000254	0.00044	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—BCHE—malignant glioma	0.00025	0.000433	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC5A5—malignant glioma	0.000247	0.000428	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—IDH2—malignant glioma	0.000247	0.000427	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTEN—malignant glioma	0.000238	0.000413	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PTK2—malignant glioma	0.000236	0.000409	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000235	0.000408	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000234	0.000406	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000234	0.000405	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000234	0.000405	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL8—malignant glioma	0.000233	0.000404	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000233	0.000403	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000232	0.000402	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000231	0.000401	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—malignant glioma	0.000231	0.0004	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CB—malignant glioma	0.000231	0.0004	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—malignant glioma	0.000229	0.000396	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MDM2—malignant glioma	0.000227	0.000394	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—RAF1—malignant glioma	0.000226	0.000392	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000226	0.000391	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAT—malignant glioma	0.000225	0.000389	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MDK—malignant glioma	0.000219	0.00038	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—malignant glioma	0.000213	0.000369	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—IDH1—malignant glioma	0.000212	0.000368	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NCOR1—malignant glioma	0.000212	0.000368	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCR3—malignant glioma	0.00021	0.000364	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DTX1—malignant glioma	0.000209	0.000362	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000205	0.000356	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000202	0.00035	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000201	0.000348	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—F2—malignant glioma	0.0002	0.000347	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTEN—malignant glioma	0.000199	0.000346	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—malignant glioma	0.000199	0.000345	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000199	0.000344	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PDGFB—malignant glioma	0.000198	0.000344	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—malignant glioma	0.000198	0.000343	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAT—malignant glioma	0.000194	0.000335	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—malignant glioma	0.000194	0.000335	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—BDKRB2—malignant glioma	0.000192	0.000333	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCR3—malignant glioma	0.000191	0.000331	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00019	0.00033	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00019	0.000329	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CAV1—malignant glioma	0.000188	0.000326	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000185	0.000321	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KRAS—malignant glioma	0.000183	0.000317	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NCOR1—malignant glioma	0.000183	0.000317	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—F2—malignant glioma	0.000179	0.00031	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—FN1—malignant glioma	0.000179	0.00031	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—KNG1—malignant glioma	0.000175	0.000303	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—BDKRB2—malignant glioma	0.000175	0.000303	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAV1—malignant glioma	0.000173	0.0003	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000173	0.000299	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CG—malignant glioma	0.000171	0.000297	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EGF—malignant glioma	0.000169	0.000293	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PTPN11—malignant glioma	0.000168	0.000292	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CA—malignant glioma	0.000168	0.000291	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000167	0.000289	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SUFU—malignant glioma	0.000166	0.000288	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000165	0.000286	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HEY2—malignant glioma	0.000164	0.000284	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000163	0.000282	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GFAP—malignant glioma	0.00016	0.000277	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KNG1—malignant glioma	0.000159	0.000275	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CG—malignant glioma	0.000157	0.000273	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT2—malignant glioma	0.000157	0.000272	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000155	0.000269	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPHK1—malignant glioma	0.000155	0.000269	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000152	0.000264	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000152	0.000264	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—malignant glioma	0.000152	0.000263	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000152	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR4—malignant glioma	0.000152	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HEY1—malignant glioma	0.000152	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CD—malignant glioma	0.000151	0.000261	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAV1—malignant glioma	0.000149	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIST1H3B—malignant glioma	0.000147	0.000256	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000142	0.000247	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BCHE—malignant glioma	0.000142	0.000246	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—malignant glioma	0.000141	0.000244	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MMP3—malignant glioma	0.000141	0.000244	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CA—malignant glioma	0.000141	0.000244	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.00014	0.000243	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000139	0.000241	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CD—malignant glioma	0.000138	0.00024	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—malignant glioma	0.000137	0.000238	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CG—malignant glioma	0.000136	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JAG2—malignant glioma	0.000135	0.000233	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RAF1—malignant glioma	0.000134	0.000233	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000132	0.000229	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CB—malignant glioma	0.000131	0.000227	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000131	0.000227	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—malignant glioma	0.000131	0.000227	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000127	0.00022	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000122	0.000211	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CB—malignant glioma	0.000121	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—malignant glioma	0.000121	0.000209	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—malignant glioma	0.00012	0.000207	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CD—malignant glioma	0.000119	0.000207	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—malignant glioma	0.000115	0.000199	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000114	0.000198	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—H3F3A—malignant glioma	0.000114	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—F2—malignant glioma	0.000113	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR3—malignant glioma	0.000113	0.000196	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—malignant glioma	0.000113	0.000195	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—YWHAE—malignant glioma	0.00011	0.00019	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK2—malignant glioma	0.00011	0.00019	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAT—malignant glioma	0.00011	0.00019	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FLT1—malignant glioma	0.000109	0.000189	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DUSP6—malignant glioma	0.000109	0.000189	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CG—malignant glioma	0.000108	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JAG1—malignant glioma	0.000107	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH3—malignant glioma	0.000107	0.000185	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FBXW7—malignant glioma	0.000105	0.000182	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—malignant glioma	0.000104	0.000181	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CB—malignant glioma	0.000104	0.00018	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NCOR1—malignant glioma	0.000104	0.00018	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BDKRB2—malignant glioma	0.000103	0.000179	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—malignant glioma	0.000103	0.000179	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—F2—malignant glioma	0.000103	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—malignant glioma	0.000102	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT2—malignant glioma	9.9e-05	0.000172	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CG—malignant glioma	9.83e-05	0.00017	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTPN11—malignant glioma	9.66e-05	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH2—malignant glioma	9.59e-05	0.000166	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CD—malignant glioma	9.52e-05	0.000165	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KNG1—malignant glioma	9.39e-05	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT2—malignant glioma	8.99e-05	0.000156	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—malignant glioma	8.99e-05	0.000156	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK1—malignant glioma	8.95e-05	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KRAS—malignant glioma	8.71e-05	0.000151	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CD—malignant glioma	8.64e-05	0.00015	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAV1—malignant glioma	8.44e-05	0.000146	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP3—malignant glioma	8.32e-05	0.000144	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CB—malignant glioma	8.29e-05	0.000144	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN2B—malignant glioma	8.24e-05	0.000143	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.07e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTK2—malignant glioma	8.01e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CA—malignant glioma	8e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—malignant glioma	7.97e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HES1—malignant glioma	7.86e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCOR1—malignant glioma	7.82e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—malignant glioma	7.74e-05	0.000134	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RAF1—malignant glioma	7.71e-05	0.000134	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CG—malignant glioma	7.69e-05	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—malignant glioma	7.62e-05	0.000132	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CB—malignant glioma	7.53e-05	0.000131	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFRA—malignant glioma	7.49e-05	0.00013	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—malignant glioma	7.42e-05	0.000129	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CA—malignant glioma	7.36e-05	0.000127	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—malignant glioma	7.27e-05	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—malignant glioma	7.24e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—malignant glioma	6.92e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TERT—malignant glioma	6.89e-05	0.000119	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CD—malignant glioma	6.76e-05	0.000117	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFB—malignant glioma	6.73e-05	0.000117	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGFR1—malignant glioma	6.69e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIF1A—malignant glioma	6.59e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—malignant glioma	6.54e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CAV1—malignant glioma	6.37e-05	0.00011	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CA—malignant glioma	6.34e-05	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KDR—malignant glioma	6.3e-05	0.000109	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FN1—malignant glioma	6.07e-05	0.000105	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2—malignant glioma	6.07e-05	0.000105	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—malignant glioma	6.01e-05	0.000104	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BAD—malignant glioma	6e-05	0.000104	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	5.94e-05	0.000103	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CB—malignant glioma	5.89e-05	0.000102	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—malignant glioma	5.84e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD80—malignant glioma	5.82e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APC—malignant glioma	5.81e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	5.81e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGF—malignant glioma	5.74e-05	9.95e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	5.7e-05	9.89e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BRAF—malignant glioma	5.46e-05	9.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT2—malignant glioma	5.31e-05	9.21e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	5.29e-05	9.17e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—malignant glioma	5.18e-05	8.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	5.1e-05	8.85e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—malignant glioma	5.09e-05	8.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	5.06e-05	8.76e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	5e-05	8.66e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGF2—malignant glioma	4.89e-05	8.47e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	4.59e-05	7.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MDM2—malignant glioma	4.57e-05	7.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RAF1—malignant glioma	4.56e-05	7.9e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	4.51e-05	7.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	4.45e-05	7.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	4.28e-05	7.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	4.13e-05	7.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—malignant glioma	4.09e-05	7.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—malignant glioma	4.09e-05	7.08e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—malignant glioma	3.87e-05	6.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—malignant glioma	3.84e-05	6.66e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	3.75e-05	6.5e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CA—malignant glioma	3.59e-05	6.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	3.47e-05	6.02e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—malignant glioma	3.44e-05	5.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—malignant glioma	3.19e-05	5.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—malignant glioma	3.12e-05	5.42e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KRAS—malignant glioma	2.95e-05	5.12e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—malignant glioma	2.93e-05	5.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	2.71e-05	4.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—malignant glioma	2.62e-05	4.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—malignant glioma	2.22e-05	3.84e-05	CbGpPWpGaD
